论文部分内容阅读
目的 :探讨益气活血方在食管癌患者放化疗中的作用。方法 :62例食管癌患者随机分为两组 ,31例行放疗和介入化疗 (A组 ) ,与 31例放疗、介入化疗和益气活血方并用 (B组 )进行比较。结果 :A、B两组近期有效率为 48 4%、64 5 % (P >0 0 5 ) ,B组骨髓功能明显高于A组 (P <0 0 1)。 1年转移率A组高于B组 (P <0 0 5 ) ,远期生存率B组明显高于A组 (P <0 0 5 )。结论 :本方能减轻放化疗造成的骨髓抑制 ,降低转移率 ,延长远期生存率 ,改善生活质量。
Objective : To explore the role of Yiqi Huoxue Fang in the treatment of esophageal cancer patients. Methods: Sixty-two patients with esophageal cancer were randomly divided into two groups. 31 patients received radiotherapy and interventional chemotherapy (group A) and 31 patients received radiotherapy, interventional chemotherapy and Yiqi Huoxue Decoction (group B). Results: The effective rates in group A and B were 48 4% and 64 5 % (P > 0 05). The bone marrow function in group B was significantly higher than that in group A (P < 0 01). The 1-year metastatic rate was higher in group A than in group B (P < 0.05), and the long-term survival rate in group B was significantly higher than that in group A (P <0 05). Conclusion: This method can reduce myelosuppression caused by radiotherapy and chemotherapy, reduce the metastasis rate, prolong the long-term survival rate, and improve the quality of life.